MAPT and early-onset autosomal dominant Alzheimer disease: Moreover, pimozide has been shown to reduce aggregation of tau protein as well as memory loss in Alzheimer’s disease models via activation of the Adenosine Monophosphate-Activated Protein Kinase (AMPK)-ULK1 axis37,61.